Although local production of DPP4 in the liver may be the most biologically relevant source for NAFLD (Miyazaki et al. 2012), decreased delivery of adipose-derived DPP4 to the liver could also contribute, possibly interacting with higher incretin delivery during obesity reversal. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.